(E)-1-(3-(4-((1-(4-Acetylphenyl)-3,3,3-trifluoroprop-1-en-1-yl)sulfonyl)phenoxy)propyl)-4-methylpiperazin-1-ium chloride

ID: ALA5194877

PubChem CID: 168284300

Max Phase: Preclinical

Molecular Formula: C24H28ClF3N2O4S

Molecular Weight: 496.55

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(=O)c1ccc(/C(=C\C(F)(F)F)S(=O)(=O)c2ccc(OCCN3CCN(C)CC3)cc2)cc1.Cl

Standard InChI:  InChI=1S/C24H27F3N2O4S.ClH/c1-18(30)19-3-5-20(6-4-19)23(17-24(25,26)27)34(31,32)22-9-7-21(8-10-22)33-16-15-29-13-11-28(2)12-14-29;/h3-10,17H,11-16H2,1-2H3;1H/b23-17+;

Standard InChI Key:  ZTSYUERKJYBUHV-YFZNFVDXSA-N

Molfile:  

     RDKit          2D

 35 36  0  0  0  0  0  0  0  0999 V2000
    4.2842    0.2065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5697   -0.2059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5697   -1.0308    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2842   -1.4433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9986   -1.0308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9986   -0.2059    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7131    0.2065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8553   -1.4433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1408   -1.0308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4262   -1.4433    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7119   -1.0308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7119   -0.2056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.2062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7146   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7146   -1.0345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0017   -1.4427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4291    0.2064    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8407    0.9222    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0158    0.9222    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1435   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1435   -1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580   -1.4435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5725   -1.8560    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5725   -1.0310    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580   -2.2684    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580    0.2064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5679   -0.2052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2840    0.2027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2840    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9986    1.4435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9986    2.2684    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7131    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5697    1.4432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580    1.0314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3219   -2.0297    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  4  5  1  0
  5  6  1  0
  6  1  1  0
  6  7  1  0
  9  8  1  0
 10  9  1  0
 11 10  1  0
 12 11  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 16 15  2  0
 11 16  1  0
 17 14  1  0
 17 18  2  0
 17 19  2  0
 17 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 22 25  1  0
 26 20  1  0
 26 27  1  0
 27 28  2  0
 29 28  1  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 33 29  2  0
 33 34  1  0
 34 26  2  0
  2  3  1  0
  3  4  1  0
  8  3  1  0
M  END

Associated Targets(Human)

T-24 (2342 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
769-P (491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHN (49357 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A498 (42825 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAKI-1 (44928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 496.55Molecular Weight (Monoisotopic): 496.1644AlogP: 3.89#Rotatable Bonds: 8
Polar Surface Area: 66.92Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.66CX LogP: 3.23CX LogD: 2.78
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.52Np Likeness Score: -0.94

References

1. Zhang J, Wang X, Chen Q, Liu J, Zhou W, Wu J..  (2022)  (E)-β-Trifluoromethyl vinylsulfones as antitumor agents: Synthesis and biological evaluations.,  232  [PMID:35189568] [10.1016/j.ejmech.2022.114197]

Source